BioArctic AB (publ)
BioArctic AB (publ) (BRCTF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BRCTF · as of Jun 8, 2026
Key Statistics
Explore BioArctic AB (publ) Data
brctf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
brctf competitorsBRCTF
ARSUF
DMPHF
GENSF
HBMHF
HTSUFStock Performance
Full HistoryAbout BioArctic AB (publ)
BioArctic AB (publ) a research-intensive biopharmaceutical company, develops biological drugs for patients with neurodegenerative disorders in Sweden. The company develops BAN2401, an immunotherapy, …
what is bioarctic ab (publ) · brctf stock overview · bioarctic ab (publ) company profile · who is bioarctic ab (publ) ceo · brctf OTC · bioarctic ab (publ) headquarters · bioarctic ab (publ) business segments
About Stock Overview & Key Data
BioArctic AB (publ) (BRCTF) is a Healthcare company in the Biotechnology industry, listed on OTC since Nov 29, 2022. As of the latest trading session, BRCTF stock price is $35.00, with a market capitalization of $3.1B. The stock has returned +86.77% over the past 12 months and +0.75% year-to-date.
In fiscal year 2025, BioArctic AB (publ) reported revenue of $2.0B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BioArctic AB (publ) (BRCTF) stock price is $35.00. The stock is traded on OTC under the ticker symbol BRCTF. The 52-week range is $18.74 – $38.75.